6110-37-8

Usage

Uses

Used in Perfumery Industry:
METHYL 2,4-DIMETHOXY-6-METHYLBENZOATE is used as a fragrance ingredient for its sweet, fruity odor, adding floral or fruity notes to perfumes and enhancing their overall scent profile.
Used in Food Industry:
METHYL 2,4-DIMETHOXY-6-METHYLBENZOATE is used as a flavoring agent in food products, imparting a sweet, fruity taste and enhancing the flavor profile of various food items.
Used in Personal Care Industry:
METHYL 2,4-DIMETHOXY-6-METHYLBENZOATE is used as a fragrance ingredient in personal care products, such as soaps, lotions, and shampoos, to provide a pleasant, fruity scent and improve the sensory experience of these products.
Used in Antimicrobial Applications:
METHYL 2,4-DIMETHOXY-6-METHYLBENZOATE has shown potential as an antimicrobial agent, making it a candidate for use in various applications where microbial control is necessary, such as in food preservation or medical settings.
Used in Antioxidant Applications:
As an antioxidant agent, METHYL 2,4-DIMETHOXY-6-METHYLBENZOATE can be utilized in various industries to prevent oxidation and extend the shelf life of products, particularly in the food and cosmetic sectors.
Used in Therapeutic Applications:
METHYL 2,4-DIMETHOXY-6-METHYLBENZOATE is being studied for its potential therapeutic applications, given its antimicrobial and antioxidant properties, which may contribute to the development of new treatments or health products.

InChI:InChI=1/C11H14O4/c1-7-5-8(13-2)6-9(14-3)10(7)11(12)15-4/h5-6H,1-4H3

Upstream product

• 186581-53-3 diazomethane 
• 520-43-4 2-hydroxy-4-methoxy-6-methyl-benzoic acid methyl ester 
• 77-78-1 dimethyl sulfate 
• 109-72-8 n-butyllithium 
• 92120-71-3 methyl 2,4-dimethoxy-6-trimethylsilylmethylbenzoate 
• 5927-18-4 trimethyl phosphonoacetate 
• 52911-90-7 2,4-dimethoxy-6-methylpyrylium fluorosulphonate 
• 3187-58-4 methyl orsellinate 
• 3686-57-5 2,4-dimethoxy-6-methylbenzoic acid 
• 480-64-8 orsellinic acid 
• 74-88-4 methyl iodide 
• 13321-73-8 2-bromo-1,5-dimethoxy-3-methylbenzene 
• 79-22-1 methyl chloroformate 
• 4179-19-5 1,3-dimethoxy-5-methylbenzene 

Downstream Products

• 71602-62-5 4-(2-methoxycarbonyl-3,5-dimethoxybenzyl)-6-methyl-2H-pyran-2-one 
• 92591-60-1 methyl 2,4-dimethoxy-5,7-dimethyl-1-naphthoate 
• 71602-67-0 methyl 6-(2-methoxycarbonyl-3,5-dimethoxyphenyl)-5-methyl-3-oxohex-4-enoate 
• 92120-71-3 methyl 2,4-dimethoxy-6-trimethylsilylmethylbenzoate 
• 92120-86-0 methyl 2-bis(trimethylsilyl)methyl-4,6-dimethoxybenzoate 
• 39503-46-3 formyl-3-dimethoxy-4,6-methyl-2-benzoate de methyle 
• 73318-23-7 2,4-Dimethoxy-6-phenylselanylmethyl-benzoic acid methyl ester 
• 130877-76-8 methyl 2,4-dimethoxy-6-(p-tolylsulfinyl) methyl benzoate 
• 67985-14-2 methyl 2,4-dimethoxy-6-[(6-methyl-4-oxo-4H-pyran-2-yl)methyl]benzoate 
• 520-43-4 2-hydroxy-4-methoxy-6-methyl-benzoic acid methyl ester 
• 56526-84-2 methyl 3-bromo-4,6-dimethoxy-2-methylbenzoate 
• 58137-74-9 methyl 4,6-dimethoxy-3-bromo-2-(bromomethyl)benzoate 
• 72911-52-5 methyl 3-iodo-4,6-dimethoxy-2-methylbenzoate 
• 70719-50-5 2-bromomethyl-4,6-dimethoxy-benzoic acid methyl ester 

Relevant academic research and scientific papers

Dimeric orsellinic acid derivatives: Valuable intermediates for natural product synthesis

Herein we report on the synthesis of dimeric orsellinates by the Ullmann reaction as well as by biomimetic oxidative phenolic coupling. The Ullmann reaction gives the 5,5′- and 3,3′-coupled dimeric orsellinates 9 and 10 regioselectively. Oxidative phenoli

Asymmetric synthesis of natural cis-dihydroarenediols using tetrahydroxynaphthalene reductase and its biosynthetic implications

Asymmetric reduction of hydroxynaphthoquinones to secondary metabolites, (3S,4R)-3,4,8- A nd (2S,4R)-2,4,8-trihydroxy-1-tetralone, a putative biosynthetic diketo intermediate and a probable natural analogue, (3S,4R)-7-acetyl-3,4,8-trihydroxy-6-methyl-3,4-

Enantioselective total synthesis of β-zearalenol from (s)-propylene oxide

The total synthesis of 14-membered resorcylic acid macrolide, β-zearalenol, was accomplished starting from commercially available enantiomerically pure propylene oxide and methyl 2,4-dihydroxy-6-methylbenzoate using Grignard reaction, asymmetric dihydroxy

Diarylvinylene similar structure compound and its preparation method and application

The invention discloses a group of diarylethene structure similar compounds as well as a preparation method and application thereof. The provided compounds have a structure of a general formula I. Moreover, the invention further provides medicinal compositions containing the compounds serving as active ingredients. Researches discover that the compounds have pharmacological activities of resisting influenza viruses, Coxsackie B3 viruses, AIDS viruses, hepatitis B viruses, hepatitis C viruses and the like. Therefore, the invention further provides the application of the compounds and the medicinal compositions containing the compounds serving as active ingredients in preparation of anti-virus medicaments. The invention lays a foundation for deeply researching and developing the application of the compounds as clinical medicaments. The general formula I is as shown in the specification.

Synthesis of (3R,5S)-5-hydroxy-de-O-methyllasiodiplodin: A facile and stereoselective approach

A concise and facile synthesis of (3R,5S)-5-hydroxy-de-O-methyllasiodiplodin has been demonstrated in 12 steps starting from methylacetoacetate and (±)propylene oxide. The key reactions involved are Jacobsen's hydrolytic kinetic resolution, Sharpless asymmetric epoxidation, Mitsunobu, and ring closing metathesis reaction for the construction of macrolactone with two chiral substitutions on it.

CAJANINE STRUCTURE ANALOGOUS COMPOUND, PREPARATION METHOD AND USE

Provided are cajanine structure analogous compounds, synthesis method and pharmacological effects thereof, the compounds of the present invention having the structure as represented by general formulas I, II, III, IV and V. Also provided are pharmaceutical compositions containing the compounds as active ingredient, and uses thereof; the compounds of the present invention having the pharmacological activities such as anti-virus, anti-virus-infection, nerve protection, anti-metabolic-diseases and the like. Also provided is a chemical total synthesis preparation method of the natural products cajanine, cajanine A and cajanine C. The present invention lays a foundation for the in-depth study and development of the compounds as clinical drugs in the future.

CAJANINE STRUCTURE ANALOGOUS COMPOUND, PREPARATION METHOD AND USE

Provided are cajanine structure analogous compounds, synthesis method and pharmacological effects thereof, the compounds of the present invention having the structure as represented by general formulas I, II, III, IV and V. Also provided are pharmaceutical compositions containing the compounds as active ingredient, and uses thereof; the compounds of the present invention having the pharmacological activities such as anti-virus, anti-virus-infection, nerve protection, anti-metabolic-diseases and the like. Also provided is a chemical total synthesis preparation method of the natural products cajanine, cajanine A and cajanine C. The present invention lays a foundation for the in-depth study and development of the compounds as clinical drugs in the future.

Synthesis of the pyranonaphthoquinones dehydroherbarin, (+)-astropaquinone B and (+)-astropaquinone C en route to ascomycones A and B

The total syntheses of the pyranonaphthoquinone natural products dehydroherbarin, (+)-astropaquinone B and (+)-astropaquinone C are described. A late stage oxidation strategy employed for the synthesis of the astropaquinones was not amenable to the conversion of dehydroherbarin into the ascomycones. The syntheses of astropaquinones B and C reported herein constitute the first total syntheses and their absolute stereochemistry was determined to be (1R,3S). Georg Thieme Verlag Stuttgart New York.

Total synthesis of (±)-cephalosol via silyl enol ether acylation

An efficient total synthesis of (±)-cephalosol is reported. Key steps are the acylation of a silyl enol ether with monomethyl oxalyl chloride and the subsequent acid-mediated ring closure to the isocoumarin structure. A chemoselective allylation and the conversion of the olefin into a methyl acetate were applied to install the γ-lactone moiety. Georg Thieme Verlag Stuttgart ? New York.

Enantioselective synthesis of the 3C-protease inhibitor (-)-thysanone by a Staunton-Weinreb annulation strategy

The total synthesis of (-)-thysanone is described. The key step involves the addition of an o-toluate anion to a lactone to create the naphthopyran framework (Staunton-Weinreb annulation). This synthesis further confirms the absolute stereochemistry of th